Melissa Carran is a Neurology physician affiliated with Cooper University Hospital. OpenAlex indexes 15 publications with 257 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3 Cooper Plz
Suite 215 (neurology)
Camden, NJ 081031438
Telephone
856-342-2445Provider last certified this registry record 22 Feb 2024.
Clinical trials
- Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Sponsor: The Cooper Health System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202531 payments
- SK Life Science, Inc.Program year20258 payments
- UCB, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.6%Other antiepileptics28.3%Levetiracetam46%Lacosamide23%Topiramate19%Xcopri5%Topamax2%Briviact2%Vimpat1%Epidiolex1%Keppra1%Levetiracetam Er1%Part D<11 patientsMood Stabilizer10%Lamotrigine51%Carbamazepine Er22%Carbamazepine13%Valproic Acid9%Lamictal3%Lamotrigine Er2%Lamotrigine Odt2%Part D<11 patients+ 22 more classes in this area
Musculoskeletal
1.7%gamma-Aminobutyric Acid-ergic Agonist0.8%Baclofen100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug0.8%Naproxen51%Diclofenac Sodium49%Part D<11 patients+ 1 more class in this area
Cardiovascular
1.4%Statin0.6%Atorvastatin Calcium100%Part D≥17 patientsBeta blocker0.3%Propranolol Hcl50%Atenolol50%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tudor Jovin, MD
Cooper University Hospital
Fred Rincon, MD
Cooper University Hospital
Naomi Lawrence, MD
Cooper University Hospital
Anthony Dragun, MD
Cooper University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”